DexCom Inc. is set to attend the 85th Scientific Sessions of the American Diabetes Association $(ADA.AU)$ in Chicago. During the event, which will take place on June 21, Dexcom will present extensive clinical data demonstrating the benefits of continuous glucose monitoring (CGM) for individuals living with Type 2 diabetes. Additionally, Grammy-nominated singer and Dexcom Warrior Lance Bass will share his personal experiences with CGM during a panel discussion.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。